Skip to main content
Menu
US

HTRF Human AQ STING Binding Kit, 500 Assay Points

This HTRF assay is designed to select and characterize compounds that specifically bind human AQ STING protein.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Protein-Protein Interaction
Sample Volume 5 µL

This HTRF assay is designed to select and characterize compounds that specifically bind human AQ STING protein.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 500 Assay Points
Part #:
64BDSTGQPEG
List Price
USD 2,091.00
Unit Size: 10,000 Assay Points
Part #:
64BDSTGQPEH
List Price
USD 24,550.00

Overview

A fast and easy way to identify new binders to human AQ STING.

Stimulator of interferon genes (STING), also known as transmembrane protein 173 (TMEM173), is a protein playing a major role in innate immunity.

The AQ and HAQ variants are found in respectively 5.2% and 20.4% of the world population. Both variants display the same binding pocket, since the R71H mutation is part of the transmembrane domain, and not expressed in the recombinant protein.

Upon intracellular cytosolic DNA release from pathogens such as viruses and bacteria, 2’-3’cGAMP binds to STING protein and triggers the secretion of type 1 interferon. The AQ variant shows a strong affinity to natural 2'-3'cGAMP and other known compounds.

Identifying new STING ligands is therefore a way to control immunity and fight autoinflammatory diseases.

Specifications

Application
Protein-Protein Interaction
Brand
HTRF
Detection Modality
HTRF
Product Group
Kit
Sample Volume
5 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Binding Assay
Target Species
Human
Technology
TR-FRET
Therapeutic Area
Infectious Diseases
Oncology & Inflammation
Unit Size
500 Assay Points

Video gallery

How it works

Assay principle

The HTRF AQ STING binding assay is a competitive assay format which uses d2-labeled AQ STING ligand, a 6His tagged human AQ STING protein, and an anti 6His Cryptate-labeled antibody. Your compound competes with the AQ STING ligand-d2 and thereby prevents FRET from occurring.

human-AQSTING-binding-kit-1.svg

 

Assay protocol

The Human AQ STING binding assay can be run in a 96- or 384-well low volume white plate (20 µL final). As described here, samples or standards are dispensed directly into the assay plate. The human His-tagged AQ STING protein is then added, followed by the dispensing of the HTRF reagents: anti 6His antibody labeled with Terbium cryptate and AQ STING ligand labeled with d2. The reagents labeled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.

human-AQSTING--binding-kit-2.svg

 

Assay validation

Compound screening

Various compounds known to be STING ligands were added to the assay.

2'3'cGAMP displays a high affinity for the AQ variant in the nM range. Similarly, the other bacterial compounds, such as 3'3' cGAMP and the reference compound ADU-S100, show Ki constants in the nM, whereas cyclic di-AMP and cyclic di-GMP are in the hundred nM range.

DMXAA, a non-specific compound, also a well-known mouse STING binder, has no effect on the assay, confirming the human specificity of the kit.

human-AQSTING--binding-kit-3.svg

 

Simplified pathway

STING simplified pathway

STING, for STimulator of INterferon Genes, is a cytoplasmic homodimeric protein localized in the endoplasmic reticulum, and which plays an essential role in innate immunity. Upon pathogen infection or mitochrondrial shrinking during apoptosis, floating dsDNAs bind and activate a DNA sensor, cyclic GMP-AMP synthase (cGAS). Activated cGAS leads to the production of 2’-3’cGAMP, a cyclic dinucleotide, which then binds to STING proteins. In turn, phosphorylated STING interacts with TANK-binding-kinase-I (TBK1), leading to the recruitment and activation of the active interferon regulatory factor (IRF3) dimer. Nuclear translocation of the IRF3 dimer leads to the transcription of genes encoding IFN-α/β. In addition, the STING pathway controls NF-κB dependent inflammatory cytokine expression. As a negative feedback loop, the DNA-stimulated cGAS-STING-TBK1 pathway also triggers STING protein degradation through p62 SQSTM1 associated autophagy, to switch off IFNb production.

human-AQSTING--binding-kit-4.svg

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Scroll Icon